DEF 14AThe Ballot
Ultragenyx Pharmaceutical Inc. files DEF 14A
Filed Apr 18, 2016 · 10y ago · Accession 0001193125-16-544873
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Ticker
- RARE
- CIK
- 1515673
- Form type
- DEF 14A
- Filing date
- Apr 18, 2016
- Report date
- Jun 9, 2016
- Document
- d140727ddef14a.htm
- Size
- 632 KB